Title:
CYCLIC HYDROCARBON COMPOUND
Document Type and Number:
WIPO Patent Application WO/2015/122494
Kind Code:
A1
Abstract:
Provided is a novel compound having an excellent suppression action against arrhythmia including atrial fibrillation and being useful as a pharmaceutical product having a separated antiviral effect. A compound indicated by general formula (I), a pharmacologically acceptable salt thereof, or a solvate of these (in the formula, the dotted line indicates a single bond and double bonds, R1 indicates a C1-6 alkyl group that may have a substituent, Q indicates an oxygen atom, a sulfur atom, or NR5, R2 indicates -(C=0)-R6, -CHR6R7, or -CH2OR8, and R3 and R4 are the same or different and indicate an amino group, an azide group, or -X-R9, provided that least either R3 or R4 is an amino group.)
More Like This:
Inventors:
MASAKI HIDEKAZU (JP)
KAGEYAMA MASAYUKI (JP)
KAGEYAMA MASAYUKI (JP)
Application Number:
PCT/JP2015/053979
Publication Date:
August 20, 2015
Filing Date:
February 13, 2015
Export Citation:
Assignee:
TOA EIYO LTD (JP)
International Classes:
C07C233/41; A61K31/165; A61K31/166; A61K31/27; A61K31/341; A61K31/381; A61K31/40; A61K31/426; A61K31/655; A61P9/06; C07C233/79; C07C247/14; C07C271/24; C07D207/335; C07D277/28; C07D307/52; C07D333/20; C07D333/22; C07D333/32
Domestic Patent References:
| WO2012147902A1 | 2012-11-01 |
Foreign References:
| JPH11501908A | 1999-02-16 |
Other References:
AKIRA TAKAHARA ET AL.: "Electrophysiological Effects of an Anti-influenza Drug Oseltamivir on the Guinea-Pig Atrium: Comparison with Those of Pilsicainide", BIOLOGICAL AND PHARMACEUTICAL BULLETIN, vol. 36, no. 10, 2013, pages 1650 - 1652, XP055219808
Attorney, Agent or Firm:
THE PATENT CORPORATE BODY ARUGA PATENT OFFICE (JP)
Patent business corporation Alga patent firm (JP)
Patent business corporation Alga patent firm (JP)
Download PDF: